0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lansoprazole Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-32M6904
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lansoprazole Market Insights Forecast to 2028
BUY CHAPTERS

Global Lansoprazole Market Research Report 2025

Code: QYRE-Auto-32M6904
Report
August 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lansoprazole Market Size

The global market for Lansoprazole was valued at US$ 394 million in the year 2024 and is projected to reach a revised size of US$ 605 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Lansoprazole Market

Lansoprazole Market

Lansoprazole drug in this report.
North American market for Lansoprazole is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lansoprazole is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan, Cisen Pharmaceutical, Lepu Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lansoprazole.
The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lansoprazole Market Report

Report Metric Details
Report Name Lansoprazole Market
Accounted market size in year US$ 394 million
Forecasted market size in 2031 US$ 605 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Male
  • Female
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan, Cisen Pharmaceutical, Lepu Pharmaceuticals, Nang Kuang Pharmaceutical, Luoxin Biotechnology, Beijing Honglin Pharma., Suzhou YUSHI Pharmaceutical Co., Changzhou Siyao Pharmaceuticals, Youcare Pharmaceutical Group, HOPE PHARMA, Sun Pharmaceutical Industries, Krka
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Lansoprazole Market growing?

Ans: The Lansoprazole Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Lansoprazole Market size in 2031?

Ans: The Lansoprazole Market size in 2031 will be US$ 605 million.

Who are the main players in the Lansoprazole Market report?

Ans: The main players in the Lansoprazole Market are Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan, Cisen Pharmaceutical, Lepu Pharmaceuticals, Nang Kuang Pharmaceutical, Luoxin Biotechnology, Beijing Honglin Pharma., Suzhou YUSHI Pharmaceutical Co., Changzhou Siyao Pharmaceuticals, Youcare Pharmaceutical Group, HOPE PHARMA, Sun Pharmaceutical Industries, Krka

What are the Application segmentation covered in the Lansoprazole Market report?

Ans: The Applications covered in the Lansoprazole Market report are Male, Female

What are the Type segmentation covered in the Lansoprazole Market report?

Ans: The Types covered in the Lansoprazole Market report are Capsules, Tablets, Injection

Recommended Reports

Gastrointestinal Drugs

Endoscopy Devices

Pulmonary & Sleep Drugs

1 Lansoprazole Market Overview
1.1 Product Definition
1.2 Lansoprazole by Type
1.2.1 Global Lansoprazole Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Injection
1.3 Lansoprazole by Application
1.3.1 Global Lansoprazole Market Value by Application (2024 VS 2031)
1.3.2 Male
1.3.3 Female
1.4 Global Lansoprazole Market Size Estimates and Forecasts
1.4.1 Global Lansoprazole Revenue 2020-2031
1.4.2 Global Lansoprazole Sales 2020-2031
1.4.3 Global Lansoprazole Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lansoprazole Market Competition by Manufacturers
2.1 Global Lansoprazole Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lansoprazole Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lansoprazole Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lansoprazole, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lansoprazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lansoprazole, Product Type & Application
2.7 Global Key Manufacturers of Lansoprazole, Date of Enter into This Industry
2.8 Global Lansoprazole Market Competitive Situation and Trends
2.8.1 Global Lansoprazole Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lansoprazole Players Market Share by Revenue
2.8.3 Global Lansoprazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lansoprazole Market Scenario by Region
3.1 Global Lansoprazole Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lansoprazole Sales by Region: 2020-2031
3.2.1 Global Lansoprazole Sales by Region: 2020-2025
3.2.2 Global Lansoprazole Sales by Region: 2026-2031
3.3 Global Lansoprazole Revenue by Region: 2020-2031
3.3.1 Global Lansoprazole Revenue by Region: 2020-2025
3.3.2 Global Lansoprazole Revenue by Region: 2026-2031
3.4 North America Lansoprazole Market Facts & Figures by Country
3.4.1 North America Lansoprazole Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lansoprazole Sales by Country (2020-2031)
3.4.3 North America Lansoprazole Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lansoprazole Market Facts & Figures by Country
3.5.1 Europe Lansoprazole Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lansoprazole Sales by Country (2020-2031)
3.5.3 Europe Lansoprazole Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lansoprazole Market Facts & Figures by Region
3.6.1 Asia Pacific Lansoprazole Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lansoprazole Sales by Region (2020-2031)
3.6.3 Asia Pacific Lansoprazole Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Lansoprazole Market Facts & Figures by Country
3.7.1 Latin America Lansoprazole Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lansoprazole Sales by Country (2020-2031)
3.7.3 Latin America Lansoprazole Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lansoprazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Lansoprazole Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lansoprazole Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lansoprazole Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lansoprazole Sales by Type (2020-2031)
4.1.1 Global Lansoprazole Sales by Type (2020-2025)
4.1.2 Global Lansoprazole Sales by Type (2026-2031)
4.1.3 Global Lansoprazole Sales Market Share by Type (2020-2031)
4.2 Global Lansoprazole Revenue by Type (2020-2031)
4.2.1 Global Lansoprazole Revenue by Type (2020-2025)
4.2.2 Global Lansoprazole Revenue by Type (2026-2031)
4.2.3 Global Lansoprazole Revenue Market Share by Type (2020-2031)
4.3 Global Lansoprazole Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lansoprazole Sales by Application (2020-2031)
5.1.1 Global Lansoprazole Sales by Application (2020-2025)
5.1.2 Global Lansoprazole Sales by Application (2026-2031)
5.1.3 Global Lansoprazole Sales Market Share by Application (2020-2031)
5.2 Global Lansoprazole Revenue by Application (2020-2031)
5.2.1 Global Lansoprazole Revenue by Application (2020-2025)
5.2.2 Global Lansoprazole Revenue by Application (2026-2031)
5.2.3 Global Lansoprazole Revenue Market Share by Application (2020-2031)
5.3 Global Lansoprazole Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Company Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Teva Pharms
6.2.1 Teva Pharms Company Information
6.2.2 Teva Pharms Description and Business Overview
6.2.3 Teva Pharms Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharms Lansoprazole Product Portfolio
6.2.5 Teva Pharms Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Company Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sandoz Lansoprazole Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK Lansoprazole Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Dr. Reddy's
6.5.1 Dr. Reddy's Company Information
6.5.2 Dr. Reddy's Description and Business Overview
6.5.3 Dr. Reddy's Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Reddy's Lansoprazole Product Portfolio
6.5.5 Dr. Reddy's Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Lansoprazole Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Taj Pharma
6.7.1 Taj Pharma Company Information
6.7.2 Taj Pharma Description and Business Overview
6.7.3 Taj Pharma Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Taj Pharma Lansoprazole Product Portfolio
6.7.5 Taj Pharma Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Lansoprazole Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Company Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cisen Pharmaceutical Lansoprazole Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 Lepu Pharmaceuticals
6.10.1 Lepu Pharmaceuticals Company Information
6.10.2 Lepu Pharmaceuticals Description and Business Overview
6.10.3 Lepu Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio
6.10.5 Lepu Pharmaceuticals Recent Developments/Updates
6.11 Nang Kuang Pharmaceutical
6.11.1 Nang Kuang Pharmaceutical Company Information
6.11.2 Nang Kuang Pharmaceutical Description and Business Overview
6.11.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio
6.11.5 Nang Kuang Pharmaceutical Recent Developments/Updates
6.12 Luoxin Biotechnology
6.12.1 Luoxin Biotechnology Company Information
6.12.2 Luoxin Biotechnology Description and Business Overview
6.12.3 Luoxin Biotechnology Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Luoxin Biotechnology Lansoprazole Product Portfolio
6.12.5 Luoxin Biotechnology Recent Developments/Updates
6.13 Beijing Honglin Pharma.
6.13.1 Beijing Honglin Pharma. Company Information
6.13.2 Beijing Honglin Pharma. Description and Business Overview
6.13.3 Beijing Honglin Pharma. Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio
6.13.5 Beijing Honglin Pharma. Recent Developments/Updates
6.14 Suzhou YUSHI Pharmaceutical Co.
6.14.1 Suzhou YUSHI Pharmaceutical Co. Company Information
6.14.2 Suzhou YUSHI Pharmaceutical Co. Description and Business Overview
6.14.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio
6.14.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments/Updates
6.15 Changzhou Siyao Pharmaceuticals
6.15.1 Changzhou Siyao Pharmaceuticals Company Information
6.15.2 Changzhou Siyao Pharmaceuticals Description and Business Overview
6.15.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio
6.15.5 Changzhou Siyao Pharmaceuticals Recent Developments/Updates
6.16 Youcare Pharmaceutical Group
6.16.1 Youcare Pharmaceutical Group Company Information
6.16.2 Youcare Pharmaceutical Group Description and Business Overview
6.16.3 Youcare Pharmaceutical Group Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio
6.16.5 Youcare Pharmaceutical Group Recent Developments/Updates
6.17 HOPE PHARMA
6.17.1 HOPE PHARMA Company Information
6.17.2 HOPE PHARMA Description and Business Overview
6.17.3 HOPE PHARMA Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.17.4 HOPE PHARMA Lansoprazole Product Portfolio
6.17.5 HOPE PHARMA Recent Developments/Updates
6.18 Sun Pharmaceutical Industries
6.18.1 Sun Pharmaceutical Industries Company Information
6.18.2 Sun Pharmaceutical Industries Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio
6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.19 Krka
6.19.1 Krka Company Information
6.19.2 Krka Description and Business Overview
6.19.3 Krka Lansoprazole Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Krka Lansoprazole Product Portfolio
6.19.5 Krka Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lansoprazole Industry Chain Analysis
7.2 Lansoprazole Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lansoprazole Production Mode & Process Analysis
7.4 Lansoprazole Sales and Marketing
7.4.1 Lansoprazole Sales Channels
7.4.2 Lansoprazole Distributors
7.5 Lansoprazole Customer Analysis
8 Lansoprazole Market Dynamics
8.1 Lansoprazole Industry Trends
8.2 Lansoprazole Market Drivers
8.3 Lansoprazole Market Challenges
8.4 Lansoprazole Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lansoprazole Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lansoprazole Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lansoprazole Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lansoprazole Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Lansoprazole Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lansoprazole Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lansoprazole Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lansoprazole Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lansoprazole, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lansoprazole, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lansoprazole, Product Type & Application
 Table 12. Global Key Manufacturers of Lansoprazole, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lansoprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lansoprazole as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lansoprazole Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lansoprazole Sales by Region (2020-2025) & (K Units)
 Table 18. Global Lansoprazole Sales Market Share by Region (2020-2025)
 Table 19. Global Lansoprazole Sales by Region (2026-2031) & (K Units)
 Table 20. Global Lansoprazole Sales Market Share by Region (2026-2031)
 Table 21. Global Lansoprazole Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lansoprazole Revenue Market Share by Region (2020-2025)
 Table 23. Global Lansoprazole Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lansoprazole Revenue Market Share by Region (2026-2031)
 Table 25. North America Lansoprazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lansoprazole Sales by Country (2020-2025) & (K Units)
 Table 27. North America Lansoprazole Sales by Country (2026-2031) & (K Units)
 Table 28. North America Lansoprazole Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lansoprazole Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lansoprazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lansoprazole Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Lansoprazole Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Lansoprazole Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lansoprazole Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lansoprazole Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lansoprazole Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Lansoprazole Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Lansoprazole Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lansoprazole Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lansoprazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lansoprazole Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Lansoprazole Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Lansoprazole Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lansoprazole Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lansoprazole Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lansoprazole Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Lansoprazole Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Lansoprazole Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lansoprazole Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lansoprazole Sales (K Units) by Type (2020-2025)
 Table 51. Global Lansoprazole Sales (K Units) by Type (2026-2031)
 Table 52. Global Lansoprazole Sales Market Share by Type (2020-2025)
 Table 53. Global Lansoprazole Sales Market Share by Type (2026-2031)
 Table 54. Global Lansoprazole Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lansoprazole Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lansoprazole Revenue Market Share by Type (2020-2025)
 Table 57. Global Lansoprazole Revenue Market Share by Type (2026-2031)
 Table 58. Global Lansoprazole Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Lansoprazole Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Lansoprazole Sales (K Units) by Application (2020-2025)
 Table 61. Global Lansoprazole Sales (K Units) by Application (2026-2031)
 Table 62. Global Lansoprazole Sales Market Share by Application (2020-2025)
 Table 63. Global Lansoprazole Sales Market Share by Application (2026-2031)
 Table 64. Global Lansoprazole Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lansoprazole Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lansoprazole Revenue Market Share by Application (2020-2025)
 Table 67. Global Lansoprazole Revenue Market Share by Application (2026-2031)
 Table 68. Global Lansoprazole Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Lansoprazole Price (USD/Unit) by Application (2026-2031)
 Table 70. Takeda Pharmaceutical Company Information
 Table 71. Takeda Pharmaceutical Description and Business Overview
 Table 72. Takeda Pharmaceutical Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Takeda Pharmaceutical Lansoprazole Product
 Table 74. Takeda Pharmaceutical Recent Developments/Updates
 Table 75. Teva Pharms Company Information
 Table 76. Teva Pharms Description and Business Overview
 Table 77. Teva Pharms Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Pharms Lansoprazole Product
 Table 79. Teva Pharms Recent Developments/Updates
 Table 80. Sandoz Company Information
 Table 81. Sandoz Description and Business Overview
 Table 82. Sandoz Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Sandoz Lansoprazole Product
 Table 84. Sandoz Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. GSK Lansoprazole Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Dr. Reddy's Company Information
 Table 91. Dr. Reddy's Description and Business Overview
 Table 92. Dr. Reddy's Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Dr. Reddy's Lansoprazole Product
 Table 94. Dr. Reddy's Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Lansoprazole Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Taj Pharma Company Information
 Table 101. Taj Pharma Description and Business Overview
 Table 102. Taj Pharma Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Taj Pharma Lansoprazole Product
 Table 104. Taj Pharma Recent Developments/Updates
 Table 105. Mylan Company Information
 Table 106. Mylan Description and Business Overview
 Table 107. Mylan Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Mylan Lansoprazole Product
 Table 109. Mylan Recent Developments/Updates
 Table 110. Cisen Pharmaceutical Company Information
 Table 111. Cisen Pharmaceutical Description and Business Overview
 Table 112. Cisen Pharmaceutical Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Cisen Pharmaceutical Lansoprazole Product
 Table 114. Cisen Pharmaceutical Recent Developments/Updates
 Table 115. Lepu Pharmaceuticals Company Information
 Table 116. Lepu Pharmaceuticals Description and Business Overview
 Table 117. Lepu Pharmaceuticals Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Lepu Pharmaceuticals Lansoprazole Product
 Table 119. Lepu Pharmaceuticals Recent Developments/Updates
 Table 120. Nang Kuang Pharmaceutical Company Information
 Table 121. Nang Kuang Pharmaceutical Description and Business Overview
 Table 122. Nang Kuang Pharmaceutical Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Nang Kuang Pharmaceutical Lansoprazole Product
 Table 124. Nang Kuang Pharmaceutical Recent Developments/Updates
 Table 125. Luoxin Biotechnology Company Information
 Table 126. Luoxin Biotechnology Description and Business Overview
 Table 127. Luoxin Biotechnology Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Luoxin Biotechnology Lansoprazole Product
 Table 129. Luoxin Biotechnology Recent Developments/Updates
 Table 130. Beijing Honglin Pharma. Company Information
 Table 131. Beijing Honglin Pharma. Description and Business Overview
 Table 132. Beijing Honglin Pharma. Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Beijing Honglin Pharma. Lansoprazole Product
 Table 134. Beijing Honglin Pharma. Recent Developments/Updates
 Table 135. Suzhou YUSHI Pharmaceutical Co. Company Information
 Table 136. Suzhou YUSHI Pharmaceutical Co. Description and Business Overview
 Table 137. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product
 Table 139. Suzhou YUSHI Pharmaceutical Co. Recent Developments/Updates
 Table 140. Changzhou Siyao Pharmaceuticals Company Information
 Table 141. Changzhou Siyao Pharmaceuticals Description and Business Overview
 Table 142. Changzhou Siyao Pharmaceuticals Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Changzhou Siyao Pharmaceuticals Lansoprazole Product
 Table 144. Changzhou Siyao Pharmaceuticals Recent Developments/Updates
 Table 145. Youcare Pharmaceutical Group Company Information
 Table 146. Youcare Pharmaceutical Group Description and Business Overview
 Table 147. Youcare Pharmaceutical Group Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Youcare Pharmaceutical Group Lansoprazole Product
 Table 149. Youcare Pharmaceutical Group Recent Developments/Updates
 Table 150. HOPE PHARMA Company Information
 Table 151. HOPE PHARMA Description and Business Overview
 Table 152. HOPE PHARMA Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. HOPE PHARMA Lansoprazole Product
 Table 154. HOPE PHARMA Recent Developments/Updates
 Table 155. Sun Pharmaceutical Industries Company Information
 Table 156. Sun Pharmaceutical Industries Description and Business Overview
 Table 157. Sun Pharmaceutical Industries Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Sun Pharmaceutical Industries Lansoprazole Product
 Table 159. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 160. Krka Company Information
 Table 161. Krka Description and Business Overview
 Table 162. Krka Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Krka Lansoprazole Product
 Table 164. Krka Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Lansoprazole Distributors List
 Table 168. Lansoprazole Customers List
 Table 169. Lansoprazole Market Trends
 Table 170. Lansoprazole Market Drivers
 Table 171. Lansoprazole Market Challenges
 Table 172. Lansoprazole Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lansoprazole
 Figure 2. Global Lansoprazole Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lansoprazole Market Share by Type: 2024 & 2031
 Figure 4. Capsules Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Injection Product Picture
 Figure 7. Global Lansoprazole Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Lansoprazole Market Share by Application: 2024 & 2031
 Figure 9. Male
 Figure 10. Female
 Figure 11. Global Lansoprazole Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Lansoprazole Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Lansoprazole Sales (2020-2031) & (K Units)
 Figure 14. Global Lansoprazole Average Price (USD/Unit) & (2020-2031)
 Figure 15. Lansoprazole Report Years Considered
 Figure 16. Lansoprazole Sales Share by Manufacturers in 2024
 Figure 17. Global Lansoprazole Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Lansoprazole Players: Market Share by Revenue in Lansoprazole in 2024
 Figure 19. Lansoprazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Lansoprazole Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Lansoprazole Sales Market Share by Country (2020-2031)
 Figure 22. North America Lansoprazole Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Lansoprazole Sales Market Share by Country (2020-2031)
 Figure 26. Europe Lansoprazole Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Lansoprazole Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Lansoprazole Revenue Market Share by Region (2020-2031)
 Figure 34. China Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Lansoprazole Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Lansoprazole Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Lansoprazole Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Lansoprazole Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Lansoprazole Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Lansoprazole by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Lansoprazole by Type (2020-2031)
 Figure 56. Global Lansoprazole Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Lansoprazole by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Lansoprazole by Application (2020-2031)
 Figure 59. Global Lansoprazole Price (USD/Unit) by Application (2020-2031)
 Figure 60. Lansoprazole Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS